Their vision is to become a leading pharmaceutical company by providing cost effective and high quality treatment and preventive medication to improve the quality of Life. Their company focusses on ensuring Quality and creating value for patients, employees and stakeholders.

Banaras Hindu University ranks among the first few in the country in the field of academic and research output. This university has two campuses, 3 institutes, 16 faculties, 140 departments, 4 advanced centers and 4 interdisciplinary schools.

Their vision is to become a leading pharmaceutical company by providing cost effective and high quality treatment and preventive medication to improve the quality of Life. Their company focusses on ensuring Quality and creating value for patients, employees and stakeholders.

The Nagpur University was established on 4th August, 1923 with six affiliated colleges and 927 students. During 1947, the number of students increased to about 9000 accompanied by the improvement and diversification of curricula and expansion in the range of subjects. The expansion of library and sports facilities occurred during these years for the intellectual and physical well being of the students.

AstraZeneca announced top-line results from SATURN. SATURN was designed to measure the impact of CRESTOR (rosuvastatin) 40 mg and atorvastatin 80 mg on the progression of atherosclerosis in high risk patients.

A New studies suggested a new hormonal therapy to reduce risk of venous thromboembolism than oral estrogen-only hormone therapy agents (contraceptive pills). In this study they compared Estradiol transdermal system with oral estrogen hormone therapy.

Tablets India Limited (TIL) is one of the leading manufacturers of various types of Pharmaceutical and nutraceutical formulations. The vital therapeutic range includes nutritional supplements, haematinics, hepatoprotectives, novel antipyretic, a unique G.I. Lavage preparation, Anti-Ulcerant, Osteoporotic Formula, Respiratory Medicine, etc.

Aventis Pharma Limited (part of the Sanofi Group) announced on 24^th August, 2011 that it has entered into a definitive agreement to acquire Universal Medicare Private Limited’s business of marketing and distribution of branded nutraceutical formulations in India. Also, approximately 750 commercial employees will transition to Aventis Pharma Ltd. The transaction has been approved by the Boards of Directors of both companies.

Health biotech is a company that promises good health for all by providing quality medicines at affordable prices and committed to care the people for keeping good health. Health Biotech has won many accolades in the domestic and international pharmaceutical domain.

ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support Clinical Development – from compound selection to Phase I - IV clinical studies

Eli Lilly India (Lilly) and Lupin Limited (Lupin) announced on 29^th July, 2011 that they have entered into a strategic collaboration to promote and distribute Lilly’s Huminsulin range of products, including Huminsulin RTM, Huminsulin NPHTM, Huminsulin 50/50TM, Huminsulin 30/70TM and Humapen Ergo II. Lupin’s India formulations business will promote and distribute the range of products in India and Nepal, virtually doubling the number of sales representatives behind the diabetes care product.

Govt. of Himachal Pradesh took up initiative in early seventies to set up a CSIR lab to make prudential use of the natural resources of the region. After several levels of discussions a formal request was made by then Chief Minister of HP to Vice President, CSIR in 1982 for initiating the matter, and giving final shape to the proposal.